2.      Zaliska O. N. The cost-effectiveness analysis of celecoxib and NSAIDs with gastroprotective agents for treatment of rheumatoid artritis in Ukraine // Value in Health. - 2002. - ISPOR 5^th Annual European

3.  Zaliska O., Zhuravchak A. Costs and clinical consequences of alfuzosin and doxazozin in benigh prostatic hyperplasia in Ukraine // ISPOR 8^th International Meeting: Programm. Arlington,USA.– 2003. – P.22.

4.      Zaliska O. Costs of pulmonary tuberculosis in Ukraine // 6^th ISPOR European Congress.-  

2003.- Programm. PIN 30.-P.18.

5.       Zaliska O. The current and future of pharmacoeconomics in Ukraine // Value in Health .- 2005.- Vol.8, № 6.- Abstract ISPOR 10^th Annual International Meeting, Washington, USA, May 15-18- Р.675.

7.        Zaliska О., Pustak K. Badania farmakoekonomiczne preparatow antyconcepcejnych na Ukrainie // III Konferencja naukowa Polskiego Towarzystwa  Farmakoekonomicznego.- Warshawa, 2005.- S. 12.

8.       Zaliska О.N., Boyko A.I. The сost of diabetes in Ukraine // Value in Health.-Vol. 7, № 6. Abstracts ISPOR 7th Annual European Congress. Hamburg, Germany-24-26 October 2004.- P.736.

9.       Zaliska О., Parnovsky B. The use of pharmacoeconomics for creation of State Formulary in Ukraine // Value in Health.-Vol. 8, № 6. Abstracts ISPOR 8^th Annual European Congress. Florencia, Italy. - 2005.- P.191.

10.   Zaliska О., Pushak K.I. A cost-effectiveness analysis of contraceptives in Ukraine // 2-^Th ISPOR Asia-

Pacific Conference. Programm.- 2006 March Shanghai, PIH6. – P.1. 

11. Zaliska O., Pushak K.I. Pharmacoeconomic analysis of oral and transdermal contraceptives in Ukraine  // Value in Health.-Vol. 11, № 6. Abstracts ISPOR 13^th ISPOR Meeting. Toronto, Canada. - 2008.- P.291.